References:
  1. Ucciferro P, Anastasopoulou C. Pseudohypoparathyroidism. [Updated 2021 Jul 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547709/
  2. Mantovani G, Linglart A, Garin I, Silve C, Elli FM, de Nanclares GP. Clinical utility gene card for: pseudohypoparathyroidism. Eur J Hum Genet. 2013 Jun. 21 (6):[Medline]. [Full Text].
  3. Hendy GN, Cole DEC, Bastepe M. Hypoparathyroidism and Pseudohypoparathyroidism. https://www.ncbi.nlm.nih.gov/books/NBK279165/#!po=0.216450
  4. Veenstra-Knol HE, Scheewe JH, van der Vlist GJ, van Doorn ME, Ausems MG. Early recognition of basal cell naevus syndrome. Eur J Pediatr. 2005 Mar;164(3):126-30. doi: 10.1007/s00431-004-1597-4. Epub 2004 Dec 10. PMID: 15717176.
  5. Evans BK, Donley DK. Pseudohypoparathyroidism, Parkinsonism syndrome, with no basal ganglia calcification. J Neurol Neurosurg Psychiatry 1988;51:709–13 Song et al. Medicine (2017) 96:11
  6. Patrizia Del Monte, Carla Micaela Cuttica, Alessandro Marugo, Luca Foppiani, Daniela Audenino, Tomasz Tadeusz Godowicz, Francesca Marta Elli, Giovanna Mantovani, Emilio Di Maria, ”Unrecognized Pseudohypoparathyroidism Type 1A as a Cause of Hypocalcemia and Seizures in a 64-Year-Old Woman”, Case Reports in Endocrinology, 2019, 8456239. https://doi.org/10.1155/2019/8456239
  7. G. Mantovani, M. Bastepe, D. Monk et al., “Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement,” Nature Reviews Endocrinology, 2018;14(8):476–500. https://doi.org/10.1155/2019/8456239
  8. G. Mantovani, M. Bastepe, D. Monk et al., “Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement,” Nature Reviews Endocrinology, vol. 14, no. 8, pp. 476–500, 2018